Moreover, genetic deletion or pharmacological inhibition of S6K1 in mice has yielded divergent metabolic and cognitive outcomes depending on sex, although this has not been systematically examined in the context of AD [36,114]. Here, RPS6KB1 is linked to Alzheimer disease.